M 106 (Zidovudine 300 mg)
Pill with imprint M 106 is White, Round and has been identified as Zidovudine 300 mg. It is supplied by Mylan Pharmaceuticals Inc..
Zidovudine is used in the treatment of hiv infection; reduction of perinatal transmission of hiv; nonoccupational exposure; occupational exposure and belongs to the drug class nucleoside reverse transcriptase inhibitors (NRTIs). Risk cannot be ruled out during pregnancy. Zidovudine 300 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for M 106
Zidovudine
- Imprint:
- M 106
- Strength:
- 300 mg
- Color:
- White
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- Nucleoside reverse transcriptase inhibitors (NRTIs)
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Mylan Pharmaceuticals Inc.
- Inactive Ingredients:
- hypromelloses
magnesium stearate
microcrystalline cellulose
polyethylene glycol
sodium starch glycolate type A potato
titanium dioxide
Note: Inactive ingredients may vary.
More about zidovudine
- Zidovudine Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Pricing & Coupons
- En Español
- Drug class: nucleoside reverse transcriptase inhibitors (NRTIs)
Consumer resources
- Zidovudine oral/injection
- Zidovudine Capsules and Tablets
- Zidovudine Injection
- Zidovudine Syrup
- Zidovudine (Advanced Reading)
- Zidovudine Intravenous (Advanced Reading)
Other brands: Retrovir
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
